Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.35 |
| ▸ | HTR5A | P47898 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.33 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.33 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8946756 | 1.00 | HTR2A (0.37) | HTR2APDK2PDK4HTR5ACYP3A4 | |
| SCHEMBL8946755 | 1.00 | HTR2A (0.37) | HTR2APDK2PDK4HTR5ACYP3A4 | |
| SCHEMBL10381583 | 0.76 | ALDH1A1 (0.42) | HTR2AMAPK1 | |
| SCHEMBL8946738 | 0.70 | HTR2A (0.33) | HTR2AMEN1KMT2A | |
| SCHEMBL8946739 | 0.70 | HTR2A (0.33) | HTR2AMEN1KMT2A | |
| SCHEMBL8946736 | 0.70 | HTR2A (0.33) | HTR2AMEN1KMT2A | |
| SCHEMBL18943506 | 0.70 | HTR5A (0.37) | HTR2AHTR5A | |
| SCHEMBL18905201 | 0.69 | NLRP3 (0.42) | HTR5APBRM1TNKS2MEN1CYP2D6 | |
| SCHEMBL12362710 | 0.63 | HTR2A (0.38) | HTR2ACYP3A4MEN1CYP2D6ALOX15 | |
| SCHEMBL12629401 | 0.63 | PDK2 (0.41) | HTR2APDK2PDK4HTR5ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0409410-B1 | Indenoindole compounds | UNIV BATH (GB) | 1996-03-20 | — | — | EP | claimed |
| US-12030900-B2 | Boron compound and organic light-emitting diode comprising same | SFC CO., LTD. (KR) | 2024-07-09 | — | — | US | disclosed |
| US-12030900-B2 | Boron compound and organic light-emitting diode comprising same | SFC CO., LTD. (KR) | 2024-07-09 | — | — | US | disclosed |
| US-20220002319-A1 | NOVEL BORON COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2022-01-06 | — | — | US | disclosed |
| US-5516788-A | TREATMENT OF ATHEROSCLEROSIS; ANTIISCHEMIC, ANTICARCINOGENIC AGENTS; ANTICOAGULANTS | UNIVERSITY OF BATH (GB) | 1996-05-14 | — | — | US | disclosed |
| EP-0409410-B1 | Indenoindole compounds | UNIV BATH (GB) | 1996-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220002319-A1 | NOVEL BORON COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CLTB, CD79B, CYBA | HTR2A 4365/4885PDK2 3276/4885PDK4 3474/4885 |
| US-12030900-B2 | Boron compound and organic light-emitting diode comprising same | CLTB, CD79B, CYBA | HTR2A 3903/4885PDK2 3095/4885PDK4 3022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.